Project Grant R01AI192795
Award Date 8/11/25
Completion Date 7/31/30
Dollars Obligated $591K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
- The federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is providing $3,519,992 to the Sloan-Kettering Institute for Cancer Research to conduct research on the chromatin architecture regulating trained immunity in antiviral natural killer (NK) cells. The research aims to better understand the molecular mechanisms that underlie trained immunity in NK cells, which play a...
- This $764,591 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research at Columbia University on the differential regulation of cell cycle entry and apoptosis in cytolytic lymphocytes. The research aims to understand how genetic variants that impact the replisome, a critical DNA replication complex, specifically affect the function and susceptibility of natural killer...
- This federal Project Grant award, valued at $735,078 and awarded on May 1, 2025, is provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The grant aims to unravel the molecular mechanisms of innate immune memory in humans, examining the epigenetic determinants that induce long-lasting "trained immunity" in human myeloid and lymphoid progenitor cells. Using single-cell gene expression...
- The Project Grant titled "IMMUNOMETABOLITE L-2-HYDROXYGLUTARATE IN NATURAL KILLER CELL ANTIVIRAL IMMUNITY" was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) on Dec 23, 2025. The $109,076 grant supports research to investigate the role of the metabolite L-2-hydroxyglutarate in regulating the function of natural killer (NK) cells and their antiviral immune response,...
- This $220,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855) will support research at the Fred Hutchinson Cancer Center in Seattle, Washington. The project aims to use a novel cell lineage tracing method called ASAP-seq to identify and characterize HIV-specific memory natural killer (NK) cells in a cohort of HIV-infected women. This will help elucidate the role of NK...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant totaling $693,465 to Cornell University on January 21, 2025 under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855). The funding will support a research project titled "Mapping Infant and Adult T Cell Immunity" that aims to construct the first molecular atlas of T cell development in lymph nodes and determine how cellular interactions and communication networks...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $156,080 to the University of Utah to study the role of the LY49C inhibitory receptor in modulating natural killer (NK) cell functions. The research aims to determine how LY49C binding to MHC-I with different peptides can lead to divergent NK cell effector functions, despite the lack of direct peptide interactions. The...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $631,977 Project Grant (CFDA 93.855 Allergy and Infectious Diseases Research) to Weill Medical College of Cornell University to conduct research aimed at enhancing immunological memory and reducing the burden of infectious diseases. The research will focus on understanding how caloric restriction induces metabolic reprogramming in memory CD8+ T cells to increase interferon production, which combines with...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $693,465 to Cornell University over a period from January 2025 to December 2029. The funding supports a research project titled "Mapping Infant and Adult T Cell Immunity" that aims to construct a molecular atlas of T cell development in lymph nodes and determine how cellular interactions and communication networks change during CD8+ T...
- This $666,567 federal Project Grant was awarded on May 13, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to identify the transcriptional regulators of human natural killer (NK) cell function following viral infection, with a focus on the role of the transcription factor MEF2C. The research aims to understand how MEF2C regulates NK cell cytotoxicity, proliferation, and...